ARTICLE | Emerging Company Profile
Alamar spinout Attovia is linking single heavy chain antibody pairs to double down on difficult therapeutic targets for cancer and immune diseases
By Danielle Golovin, Biopharma Analyst
June 21, 2023 1:09 AM UTC
Attovia launched Tuesday with $60 million in series A funding to develop linked pairs of single-domain antibodies that bind different epitopes of the same antigen, which improves their specificity and affinity.
Frazier Life Sciences led the round, with participation from venBio Partners and Illumina Ventures…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- EVM Finance. Unified Interface for Decentralized Finance. Access Here.
- Quantum Media Group. IR/PR Amplified. Access Here.
- PlatoAiStream. Web3 Data Intelligence. Knowledge Amplified. Access Here.
- Source: https://www.biocentury.com/article/648346/attovia-improving-affinity-and-specificity-using-linked-nanobodies
